A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.
Clinical trial NCT04390334 · COMPLETED
Trial details
- NCT number
- NCT04390334
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-13
- Primary completion
- 2020-06-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.